Patent 8034370 was granted and assigned to Allergan, Inc. on October, 2011 by the United States Patent and Trademark Office.
The invention provides biodegradable implants sized for implantation in an ocular region and methods for treating medical conditions of the eye. The implants are formed from a mixture of hydrophilic end and hydrophobic end PLGA, and deliver active agents into an ocular region without a high burst release.